Earnings · China A-shares
China National Medicines Corporation Ltd. Class A (600511) earnings
China National Medicines Corporation Ltd. Class A published its Q3 report on 2026-10-20: net profit -1.07% year on year, +0.36% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +1.60% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-20
- Period end
- 2026-09-30
- Net profit YoY
- -1.07%
- Excl. one-offs YoY
- +0.36%
- Net profit QoQ
- +47.09%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.64% | — |
| 3 days | +1.60% | — |
| 7 days | +3.23% | — |
| 14 days | +7.95% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -0.51%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-21 | ¥1.48B | -1.07% | +0.36% | +3.11% | 1.96 | 7.79% | +1.60% | — | — |
| 2026 interim report | 2026-08-20 | ¥879.77M | -7.25% | -5.55% | +4.27% | 1.17 | 4.69% | -3.28% | -3.17% | +2.52% |
| 2026 Q1 report | 2026-04-23 | ¥474.26M | +3.32% | +4.22% | +6.63% | 0.63 | 2.52% | +0.60% | -5.99% | -4.43% |
| 2025 annual report | 2026-03-20 | ¥2.00B | -0.18% | -1.28% | +3.70% | 2.65 | 11.26% | -2.22% | -2.60% | -8.98% |
| 2025 Q3 report | 2025-10-22 | ¥1.49B | +0.74% | -1.27% | +3.56% | 1.98 | 8.50% | +2.64% | +1.11% | +2.45% |
| 2025 interim report | 2025-08-21 | ¥948.55M | -5.19% | -7.14% | +3.54% | 1.26 | 5.45% | +1.43% | -4.00% | -14.68% |
| 2025 Q1 report | 2025-04-25 | ¥459.02M | -0.10% | -2.57% | +4.87% | 0.61 | 2.64% | -1.43% | +4.32% | +1.08% |
| 2024 annual report | 2025-03-20 | ¥2.00B | -6.80% | -4.63% | +1.81% | 2.65 | 12.24% | -3.40% | -5.17% | +1.34% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.